PharmiNews

The Directory of Pharma Companies and News

Pfizer

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us. To learn more, please visit us at www.pfizer.com.
Category:
Category:

Pfizer News

DateNews
2017-08-03FDA Advisory Committee Votes in Favor of XELJANZ® (tofacitinib citrate) for the Treatment of Active Psoriatic Arthritis
2017-08-01Pfizer Reports Second-Quarter 2017 Results
2017-07-24Pfizer Announces Positive Top-Line Results from the Comparative REFLECTIONS B7391003 Study for PF-06439535, a Potential ...
2017-07-21EMA's CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma
2017-07-20Merck and Pfizer Collaborate with Corning
2017-07-20Pfizer Completes License Agreement For The Exclusive Commercialization Rights In Europe For CRESEMBA (isavuconazole)
2017-07-13Pfizer Announces FDA Accepts Supplemental New Drug Application for XELJANZ® (tofacitinib citrate) for the Treatment of A...
2017-07-11FDA Advisory Committee Votes in Favor of Pfizer’s MYLOTARG (gemtuzumab ozogamicin) for Acute Myeloid Leukemia
2017-06-30BESPONSA® Approved in the EU for Adult Patients with Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemi...
2017-06-27Pfizer Breaks Ground on New R&D Facility in Chesterfield, Missouri
2017-01-05Pfizer Announces Positive Top-Line Results from the Comparative REFLECTIONS B538-02 Study for PF-06410293, a Potential B...
2017-01-03Pfizer Invites Public To View And Listen To Webcast Of January 31 Conference Call With Analysts
2016-12-23Pfizer Completes Acquisition of Small Molecule Anti-Infective Business From AstraZeneca
2016-12-21FDA Accepts Supplemental New Drug Application for Pfizer’s IBRANCE® (palbociclib) in HR+, HER2- Metastatic Breast Cancer
2016-12-19Pfizer Presents Data from PALOMA-2 Phase 3 Study Demonstrating Clinical Benefit of IBRANCE® (palbociclib) in Asian Women...
2016-12-19Pfizer Receives Approval in the European Union for Nimenrix™ (Meningococcal Group A, C, W-135, and Y Conjugate Vaccine) ...
2016-12-16FDA Approves Removal Of Boxed Warning Regarding Serious Neuropsychiatric Events From CHANTIX® (varenicline) Labeling
2016-12-15Pfizer Receives FDA Approval for EUCRISA™ (crisaborole), a Novel Non-Steroidal Topical Ointment for Mild to Moderate Ato...
2016-12-14Pfizer and Astellas Announce Top-Line Results from Phase 4 PLATO Trial of XTANDI® (enzalutamide) Capsules in Patients wi...
2016-09-28Pfizer to Showcase Progress of Broad-Based Oncology Portfolio at European Society for Medical Oncology (ESMO) 2016 Congr...
2016-09-28Pfizer Completes Acquisition of Medivation
2016-09-26Pfizer Decides Remaining One Company Best Positions Company To Maximize Future Value Creation
2016-09-23Pfizer Announces Expiration of HSR Waiting Period For Proposed Acquisition of Medivation
2016-09-22Pfizer Declares 30-Cent Fourth-Quarter 2016 Dividend
2016-09-22Pfizer Invites Public To View And Listen To Webcast Of November 1 Conference Call With Analysts
2016-09-16Pfizer Receives Positive CHMP Opinion For IBRANCE® (palbociclib) In Combination With Endocrine Therapy For The Treatment...
2016-09-16Pfizer Announces Positive Top-Line Results from REFLECTIONS B537-02 Study for PF-06438179 (infliximab-Pfizer) a Potentia...
2016-09-15Merck and Pfizer Announce Investigational Ertugliflozin Met Primary Endpoint of A1C Reduction When Added to Sitagliptin ...
2016-09-14FDA Advisory Committees Recommend to Remove Boxed Warning in Labeling for Pfizer’s Smoking Cessation Therapy, CHANTIX® (...
2016-09-13Pfizer Launches New “Moodivator” App to Help Support, Encourage and Motivate People with Depression
2016-09-07Pfizer Appoints Chief Scientific Officer for Neuroscience Research
2016-09-06Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Morgan Stanley Global Healthcare Conference
2016-08-31XALKORI® (Crizotinib) Receives Approval In European Union For The Treatment Of Patients With ROS1-Positive Advanced Non-...
2016-08-24Pfizer To Acquire Small Molecule Anti-Infective Business From AstraZeneca
2016-08-23Bristol-Myers Squibb and Pfizer to Present New Eliquis (apixaban) Analyses at ESC Congress 2016
2016-08-22Pfizer To Acquire Medivation
2016-08-19FDA Approves TROXYCA® ER (oxycodone hydrochloride and naltrexone hydrochloride) Extended-Release Capsules CII with Abuse...
2016-08-08Pfizer Announces Publication of New Analysis Showing Long-Term Therapy with VYNDAQEL (tafamidis) Slowed Progression of R...
2016-08-02PFIZER REPORTS SECOND-QUARTER 2016 RESULTS
2016-08-01PFIZER AIMS TO BECOME INDUSTRY LEADER IN GENE THERAPY WITH AQUISITION OF BAMBOO THERAPEUTICS, INC.
2016-07-28Pfizer and Western Oncolytics Announce Immuno-Oncology Research Collaboration to Investigate Novel Oncolytic Virus Techn...
2016-07-28Pfizer Announces Positive Top-Line Results from Pivotal Phase 3 Maintenance Trial of Oral XELJANZ® (Tofacitinib Citrate)...
2016-07-21Spark Therapeutics and Pfizer Announce Receipt of FDA Breakthrough Therapy Designation for SPK-9001 for the Treatment of...
2016-07-19Pfizer Receives World Health Organization Prequalification for Multi-Dose Vial Presentation of Prevenar 13®
2016-07-13Pfizer Announces the Publication of Final Results from Two Pivotal Phase 3 Studies of Crisaborole Topical Ointment in Pa...
2016-07-12Pfizer Receives FDA Approval for Prevnar 13® in Adults Age 18 Through 49
2016-07-08Pfizer Announces Positive Top-Line Results From Phase 3 S-TRAC Trial of SUTENT® (sunitinib) as Adjuvant Therapy in Patie...
2016-07-06Merck KGaA, Darmstadt, Germany, and Pfizer Initiate Phase III Trial to Evaluate Avelumab as First-line Treatment for Ova...
2016-06-28Two Additional Phase 3 Lipid-Lowering Studies of Bococizumab Deliver Positive Topline Results
2016-06-28Pfizer Advances Biosimilars Leadership with Investment in a New World-Class Global Biotechnology Center in China
2016-06-24Pfizer Completes Acquisition of Anacor
2016-06-23Pfizer Declares 30-Cent Third-Quarter 2016 Dividend
2016-06-21Pfizer Invites Public To View And Listen To Webcast Of August 2 Conference Call With Analysts
2016-06-16Help Pfizer Change The Future Of Healthy Aging
2016-06-16Pfizer Breaks Ground On New Biologics Clinical Manufacturing Facility In Andover, Massachusetts
2016-06-13Merck and Pfizer Announce Two Pivotal Phase 3 Studies for Ertugliflozin, an Investigational SGLT-2 Inhibitor, Met Primar...
2016-06-12Pfizer Announces Final Results from Inotuzumab Ozogamicin Pivotal Phase 3 Study in Adults with Relapsed/Refractory Acute...
2016-06-09Pro Golfer Jim Furyk Teams Up With Pfizer To Raise Awareness For Pneumococcal Pneumonia And The Importance Of Older Adul...
2016-06-08Pfizer Research Advances Body Of Evidence For Tofacitinib Citrate (XELJANZ®) Providing Clinicians With Additional Inform...
2016-06-08Pfizer Announces FDA Advisory Committees’ Recommend ALO-02 (oxycodone hydrochloride and naltrexone hydrochloride) Extend...
2016-06-07A Mother’s Mission to Help Prevent Another Life Lost to MenB
2016-06-07Pfizer Announces Positive Top-Line Results from Second Phase 3 Trial of Oral XELJANZ® (Tofacitinib Citrate) in Adults wi...
2016-06-06ASCO 2016: Pivotal Avelumab Study Shows Positive Results in Metastatic Merkel Cell Carcinoma
2016-06-06Pfizer Presents Promising Data from Next Generation ALK/ROS1 Inhibitor in Advanced Non-Small Cell Lung Cancer
2016-06-04Pfizer Presents Data from Phase 1b Trial Investigating Utomilumab (a 4-1BB agonist) in Combination with a Checkpoint Inh...
2016-05-23CHAMPIX® (varenicline) European Union Label Updated to Include New Safety and Efficacy Data from the EAGLES Clinical Tri...
2016-05-20Pfizer Announces European Medicines Agency Acceptance for Review of Marketing Authorization Application for TRUMENBA® (M...
2016-05-20Spark Therapeutics and Pfizer Announce Data from Initial Subjects in Hemophilia B Trial Demonstrating Consistent Therape...
2016-05-18Merck KGaA, Darmstadt, Germany, and Pfizer to Present Avelumab Data in Seven Different Cancers at ASCO Annual Meeting
2016-05-18Pfizer to Showcase Diverse and Growing Oncology Portfolio at the American Society of Clinical Oncology (ASCO) 2016 Annua...
2016-05-17Global Survey Finds Disconnects Between Physicians and People Living With Rheumatoid Arthritis (RA)
2016-05-16Pfizer to Acquire Anacor
2016-05-13Pfizer Presents Results from Two Phase 3 TRUMENBA® (Meningococcal Group B Vaccine) Studies at the European Society for P...
2016-05-11Pfizer Awards More Than $1 Million in Metastatic Breast Cancer Research Funding Through Breast Cancer: A Story Half Told...
2016-05-03PFIZER REPORTS FIRST-QUARTER 2016 RESULTS
2016-04-26Bococizumab SPIRE-2 Cardiovascular Outcome Study Fully Enrolled
2016-04-22CHANTIX®/CHAMPIX® (varenicline) Results from the Largest Global Clinical Trial of Smoking Cessation Medicines Published ...
2016-04-21Pfizer Invites Public to Listen to Webcast of April 28 Annual Meeting of Shareholders
2016-04-19Pfizer Announces Positive Top-Line Results for Phase 3 PALOMA-2 Clinical Trial of IBRANCE® (palbociclib)
2016-04-07Pfizer Taps IBM for Research Collaboration to Transform Parkinson’s Disease Care
2016-04-06Pfizer Announces Termination of Proposed Combination with Allergan
2016-04-06Pfizer Receives European Approval for New Multi-Dose Vial Presentation of Prevenar 13®
2016-04-05Merck and Pfizer Announce First Patient Treated in Phase III Combination Study with Avelumab and INLYTA® in Renal Cell C...
2016-04-05Pfizer Announces Positive Top-Line Results from the First Phase 3 Trial of Investigational Tofacitinib in Adults with Ps...
2016-04-05Pfizer and Allergan Issue Statement
2016-04-05FDA Approves INFLECTRA™ (Biosimilar Infliximab), The First U.S. Biosimilar Monoclonal Antibody, For All Eligible Indicat...
2016-04-01Pfizer Announces Positive Topline Results from Second Phase 3 Lipid-Lowering Study Evaluating Bococizumab
2016-03-31Pfizer Inc. (NYSE: PFE) today issued the following statement:
2016-03-30Pfizer and Allergan Receive Request for Additional Information from Federal Trade Commission Regarding Proposed Combinat...
2016-03-30Bristol-Myers Squibb and Pfizer Announce Global Real-World Data Program and Present New Analyses of Eliquis (apixaban) a...
2016-03-23Pfizer Announces European Medicines Agency Accepted for Review Its Marketing Authorization Application for XELJANZ® (Tof...
2016-03-22Pfizer Joins The Human Vaccines Project To Help Decode The Immune System
2016-03-22Pfizer Invites Public to View and Listen to Webcast of May 3 Conference Call with Analysts
2016-03-18Pfizer Announces Oral Tofacitinib, an Investigational JAK Inhibitor, Meets Primary and Key Secondary Endpoints in Two Pi...
2016-03-16Pfizer to Present New Data on Investigational Tofacitinib in Inflammatory Bowel Disease at the 11th Congress of ECCO
2016-03-15Pfizer Celebrates a Year of Achievements in 2015 Annual Review
2016-03-11XALKORI® (crizotinib) Approved by U.S. FDA for the Treatment of Patients with ROS1-Positive Metastatic Non-Small Cell Lu...
2016-03-09New Survey Reveals Many Living with Symptoms of Diabetic Nerve Pain Are Undiagnosed Despite Severe and Constant Pain
2016-03-09Pfizer Commences $5 Billion Accelerated Share Repurchase
2016-03-09Pfizer Announces Publication of Study Results of BeneFIX® Coagulation Factor IX (Recombinant) Once-Weekly Prophylaxis fo...
2016-03-08Pfizer Consumer Healthcare and frog Launch Design Collaborative
2016-02-24Pfizer Announces FDA Approval of XELJANZ® XR (tofacitinib citrate) Extended-Release Tablets, the First and Only Once-Dai...
2016-02-19Pfizer Receives Expanded FDA Approval For IBRANCE (palbociclib) In HR+, HER2- Metastatic Breast Cancer
2016-02-16WYETH REACHES AGREEMENT IN PRINCIPLE TO RESOLVE MEDICAID DRUG REBATE CLAIMS FOR 2001-2006 PERIOD FOR PROTONIX
2016-02-09Pfizer Commends The FDA Advisory Committee’s Vote To Approve Proposed Biosimilar Infliximab, The First Biosimilar Monocl...
2016-02-08Pfizer Names Executive Leadership Team for Combined Organization Upon Close of Proposed Allergan Transaction
2016-02-02PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2015 RESULTS PROVIDES 2016 FINANCIAL GUIDANCE
2016-02-01Bristol-Myers Squibb and Pfizer Sign Collaboration with Portola Pharmaceuticals to Develop and Commercialize Investigati...
2016-01-08Pfizer Expands R&D Equity Investment Strategy to Access Early-Stage Scientific Innovations
2016-01-08Pfizer Enters into Translational Research Collaboration with Adaptive Biotechnologies to Help Advance Novel Immuno-Oncol...
2016-01-04Merck KGaA, Darmstadt, Germany, Pfizer and Syndax Announce Collaboration to Evaluate Combination of Avelumab and Entinos...
2015-12-22Pfizer Invites Public To View And Listen To Webcast Of February 2 Conference Call With Analysts
2015-12-22Merck KGaA, Darmstadt, Germany and Pfizer Advance Clinical Development Program with Two Additional Phase III Trials of A...
2015-12-14Pfizer Declares First-Quarter 2016 Dividend
2015-12-14Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference
2015-12-10Pfizer Announces FDA Acceptance of IBRANCE® (palbociclib) Supplemental New Drug Application with Priority Review in HR+,...
2015-12-10AMPLIFY Post-Hoc Early Time Course Analysis Evaluated Recurrent Venous Thromboembolism (VTE), VTE-Related Death and Majo...
2015-12-09Merck KGaA, Darmstadt, Germany, and Pfizer Initiate Two Phase III Studies of Investigational Immunotherapy Avelumab in A...
2015-12-08Pfizer Awards More Than $4 Million in Grants to Further Clinical Research in Advanced Breast Cancer for 2015
2015-12-08Pfizer Announces U.S. FDA Acceptance and Priority Review of Supplemental New Drug Application for XALKORI® (crizotinib) ...
2015-12-07Pfizer Receives U.S. FDA Approval of New QuilliChew ER™ (methylphenidate hydrochloride) extended-release chewable tablet...
2015-12-01Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
2015-11-30Pfizer Reports Top-Line Results from a Phase 3 Study of LYRICA® (pregabalin) Capsules CV in Adults with Post-Traumatic P...
2015-11-30Merck KGaA, Darmstadt, Germany, and Pfizer Receive Positive Opinion for Orphan Drug Designation for Avelumab in Merkel C...
2015-11-30Pfizer Receives European Approval to Expand Use of XALKORI® (crizotinib) to First-Line Treatment of Adults with ALK-Posi...
2015-11-23Pfizer and Allergan to Combine
2015-11-18Pfizer Reports Positive Topline Results from Phase 3 Trial Comparing XALKORI® (crizotinib) to Chemotherapy in Previously...
2015-11-18Merck KGaA, Darmstadt, Germany, and Pfizer Receive FDA Breakthrough Therapy Designation for Avelumab in Metastatic Merke...
2015-11-16Global Partners Announce Donation of 500 Millionth Dose of Azithromycin, Marking Exceptional Progress to Help Alleviate ...
2015-11-06Bristol-Myers Squibb and Pfizer to Present New Data on Eliquis (apixaban) at the American Heart Association (AHA) Scient...
2015-11-05Global Analysis Of Metastatic Breast Cancer Landscape Reveals Gaps In Patient Care And Support
2015-11-05Pfizer Expands its Patient Assistance Program, Doubling the Income Eligibility Limit to Benefit Even More Patients Takin...
2015-11-04Merck KGaA, Darmstadt, Germany, and Pfizer Announce Initiation of Phase III First-Line Trial of Avelumab in Patients wit...
2015-11-02New Data Continue to Characterize the Safety and Efficacy of XELJANZ® (tofacitinib citrate) in the Treatment of Rheumato...
2015-10-29Announcement Regarding Allergan plc
2015-10-29Pfizer Announces Collaboration with GSK on Next-Generation Design of Portable, Continuous, Miniature and Modular (PCMM) ...
2015-10-27PFIZER REPORTS THIRD-QUARTER 2015 RESULTS
2015-10-19Pfizer’s Inotuzumab Ozogamicin Receives FDA Breakthrough Therapy Designation for Acute Lymphoblastic Leukemia (ALL)
2015-10-14Pfizer Receives Complete Response Letter from FDA for Oral XELJANZ® (tofacitinib citrate) Supplemental New Drug Applicat...
2015-10-13Pfizer and the Union for International Cancer Control Award 20 Grants Totaling $760,000 to Address the Needs of Metastat...
2015-10-09Pfizer’s Phase 2 Study Demonstrates Safety, Tolerability and Immunogenicity of TRUMENBA® When Coadministered with Mening...
2015-10-07Merck KGaA, Darmstadt, Germany, and Pfizer Announce Investigational Immunotherapy Avelumab Receives FDA Fast Track Desig...
2015-10-02Pfizer Inc. Announces Final Results of Exchange Offers
2015-10-01Pfizer Completes Acquisition Of Nimenrix And Mencevax From GlaxoSmithKline
2015-09-30Pfizer Updates 2015 Financial Guidance Solely to Include Hospira Operations In Financial Results From September 3, 2015 ...
2015-09-30Is 50 Really the New 30? Your Immune System May Not Think So
2015-09-30Pfizer Partners with Breast Cancer Leaders to Chronicle the Lives of Women with Metastatic Breast Cancer through the Len...
2015-09-24Pfizer’s Sayana® Press Becomes First Injectable Contraceptive In The United Kingdom Available For Administration By Self...
2015-09-22New Centrum® VitaMints® Offer a Refreshingly New Way to Take a Multivitamin
2015-09-21Pfizer Announces Positive Top-Line Results from Two Phase 3 Trials of Oral Tofacitinib in Adults with Moderate-to-Severe...
2015-09-18Pfizer Inc. Announces Results of Early Tenders and Consents in Exchange Offers
2015-09-17Pfizer Invites Public to View and Listen to Webcast of October 27 Conference Call with Analysts
2015-09-11Merck KGaA, Darmstadt, Germany and Pfizer to Present Updates for Avelumab at the European Cancer Congress 2015
2015-09-09Bristol-Myers Squibb and Pfizer Enroll First Patient in Phase 4 AUGUSTUS Trial to Evaluate Safety of Eliquis (apixaban) ...
2015-09-03Pfizer Completes Acquisition of Hospira
2015-09-03Pfizer Inc. Commences Exchange Offers for Hospira Notes
2015-08-26Alliance Foundation Trials and Austrian Breast & Colorectal Cancer Study Group Open Largest Global Phase 3 Trial of Targ...
2015-08-24Bristol-Myers Squibb and Pfizer to Present New Data on Eliquis (apixaban) at the ESC Congress 2015
2015-08-24Pfizer Receives Clearance from U.S. Federal Trade Commission for Hospira Acquisition
2015-08-21Pfizer Announces Positive Topline Results Of Two Phase 3 Studies Of TRUMENBA® (Meningococcal Group B Vaccine)
2015-08-20Pfizer Announces European Medicines Agency Validates Marketing Authorization Application for IBRANCE® (palbociclib) in C...
2015-08-14Pfizer Granted Approval From The Canadian Competition Bureau For Hospira Acquisition
2015-08-13Pfizer Receives Approval from the Australian Competition and Consumer Commission for Pending Acquisition of Hospira
2015-08-04Pfizer Receives Approval From European Commission For Pending Acquisition Of Hospira
2015-08-03Pfizer and Synthon Enter Into U.S. Commercialization Agreement for Potential Generic Treatment of Multiple Sclerosis
2015-07-28PFIZER REPORTS SECOND-QUARTER 2015 RESULTS
2015-07-22Pfizer Announces Expansion of Lease Agreement with Massachusetts Institute of Technology Subsidiary for Kendall Square R...
2015-07-08Pfizer’s Centers For Therapeutic Innovation And Jeffrey Modell Foundation Announce Collaboration to Help Advance Immunol...
2015-07-07Pfizer Begins Phase 2b Study Of Its Investigational Multi-antigen Staphylococcus aureus Vaccine In Adults Undergoing Ele...
2015-07-02Pfizer Announces FDA Acceptance for Review of New Drug Application for A Once-Daily Formulation of XELJANZ® (tofacitinib...
2015-06-25Joseph J. Echevarria Elected To Pfizer’s Board Of Directors
2015-06-25Pfizer Declares 28-Cent Third-Quarter 2015 Dividend
2015-06-24CDC Advisory Committee on Immunization Practices Votes to Recommend Serogroup B Meningococcal Disease Vaccination includ...
2015-06-23New Online Community, Quitter’s Circle, Helps Smokers Trade Cigarettes for Real-Time Support
2015-06-23Pfizer Announces Enrollment Of First Patient In Phase 3 Trial In Sickle Cell Disease
2015-06-23Pfizer Invites Public To View And Listen To Webcast Of July 28 Conference Call With Analysts
2015-06-22Pfizer Enters Into Agreement To Acquire Nimenrix And Mencevax From GlaxoSmithKline
2015-06-11Pfizer Reports Top Line Results from a Phase 3 Study Evaluating Desvenlafaxine Succinate Sustained-Release Formulation i...
2015-06-10Pfizer Builds Upon Robust Body Of Knowledge For XELJANZ® (tofacitinib citrate) With Clinical Trial And Real-World Use Da...
2015-06-08Pfizer Announces 12 Presentations Including New Research Data on Tofacitinib for Chronic Plaque Psoriasis and Atopic Der...
2015-06-04Get Ready. Get Set. Get Old. Pfizer Challenges Conventional Views of Aging Through New Campaign
2015-05-30Pfizer Announces Palbociclib More Than Doubled Progression-Free Survival in Phase 3 Trial for Patients With HR+, HER2- M...
2015-05-29Pfizer’s RAPAMUNE® (sirolimus) Becomes First FDA-Approved Treatment for Lymphangioleiomyomatosis (LAM), A Rare Progressi...
2015-05-28Pfizer Announces $3 Million Grants Program to Further Clinical Research in Advanced Breast Cancer
2015-05-28Pfizer Global Survey Finds Adults with Rheumatoid Arthritis Who Feel Comfortable Speaking Up About Their Concerns Have a...
2015-05-19Pfizer Invites Public to View and Listen to Webcast of June 2 Conference Call with Analysts to Review Oncology Business ...
2015-05-14Marc Tessier-Lavigne, Ph.D. to Leave Pfizer Board of Directors
2015-05-14Pfizer Receives Request For Additional Information From FTC Regarding Proposed Acquisition Of Hospira
2015-05-13Merck KGaA, Darmstadt, Germany, and Pfizer to Present Data at ASCO for Avelumab, an Investigational Anti-PD-L1 Antibody
2015-05-11Pfizer Acquires Minority Interest in AM-Pharma; Secures Option to Acquire Company
2015-05-06Pfizer Appoints New Leaders for BioTherapeutics Research & Development and Rinat
2015-04-28PFIZER REPORTS FIRST-QUARTER 2015 RESULTS
2015-04-23Pfizer Hosts Annual Meeting Of Shareholders
2015-04-21Pfizer Phase 3 Study Of Inotuzumab Ozogamicin Meets Primary Endpoint In Adult Patients With Relapsed Or Refractory Acute...
2015-04-21Pfizer Receives U.S. FDA Breakthrough Therapy Designation For XALKORI® (crizotinib) For The Treatment Of Patients With R...
2015-04-20Global Strategic Partners Merck KGaA, Darmstadt, Germany, and Pfizer Initiate Phase III Study with Avelumab* in Patients...
2015-04-16Pfizer Launches 2014 Integrated Annual Review
2015-04-16Pfizer Invites Public to Listen to Webcast of April 23 Annual Meeting of Shareholders
2015-04-15Pfizer Announces PALOMA-3 Trial For IBRANCE® (Palbociclib) Stopped Early Due To Efficacy Seen In Patients With HR+, HER2...
1970-01-01\u003cp style=\"text-align: left;\"\u003e\u003cstrong\u003eCHMP announces positive opinion for biosimilar rituximab Trux... (PDF)
1970-01-01Mundipharma announced that Penthrox® (low dose methoxyflurane) has been granted marketing authorisation in France for th... (PDF)
Brought to you by PharmiWeb.com - Latest Jobs in Pharma
Brought to you by www.pharmiweb.com - Latest Jobs in Pharma.